Moberg Pharma AB (publ)

Moberg Pharma AB (publ) is a Swedish specialty pharmaceutical company focused on dermatology. Its lead product MOB-015 / Terclara is a topical terbinafine treatment for nail fungus, approved in multiple markets and launched in the Nordics.